158 related articles for article (PubMed ID: 24371266)
1. Active site plasticity enables metal-dependent tuning of Cas5d nuclease activity in CRISPR-Cas type I-C system.
Punetha A; Sivathanu R; Anand B
Nucleic Acids Res; 2014 Apr; 42(6):3846-56. PubMed ID: 24371266
[TBL] [Abstract][Full Text] [Related]
2. Conservation and variability in the structure and function of the Cas5d endoribonuclease in the CRISPR-mediated microbial immune system.
Koo Y; Ka D; Kim EJ; Suh N; Bae E
J Mol Biol; 2013 Oct; 425(20):3799-810. PubMed ID: 23500492
[TBL] [Abstract][Full Text] [Related]
3. Cas5d protein processes pre-crRNA and assembles into a cascade-like interference complex in subtype I-C/Dvulg CRISPR-Cas system.
Nam KH; Haitjema C; Liu X; Ding F; Wang H; DeLisa MP; Ke A
Structure; 2012 Sep; 20(9):1574-84. PubMed ID: 22841292
[TBL] [Abstract][Full Text] [Related]
4. Assembly of Cas7 subunits of Leptospira on the mature crRNA of CRISPR-Cas I-B is modulated by divalent ions.
Hussain MS; Kumar M
Gene; 2022 Apr; 818():146244. PubMed ID: 35074418
[TBL] [Abstract][Full Text] [Related]
5. Structural plasticity and in vivo activity of Cas1 from the type I-F CRISPR-Cas system.
Wilkinson ME; Nakatani Y; Staals RH; Kieper SN; Opel-Reading HK; McKenzie RE; Fineran PC; Krause KL
Biochem J; 2016 Apr; 473(8):1063-72. PubMed ID: 26929403
[TBL] [Abstract][Full Text] [Related]
6. Genome editing in mammalian cells using the CRISPR type I-D nuclease.
Osakabe K; Wada N; Murakami E; Miyashita N; Osakabe Y
Nucleic Acids Res; 2021 Jun; 49(11):6347-6363. PubMed ID: 34076237
[TBL] [Abstract][Full Text] [Related]
7. The host-encoded RNase E endonuclease as the crRNA maturation enzyme in a CRISPR-Cas subtype III-Bv system.
Behler J; Sharma K; Reimann V; Wilde A; Urlaub H; Hess WR
Nat Microbiol; 2018 Mar; 3(3):367-377. PubMed ID: 29403013
[TBL] [Abstract][Full Text] [Related]
8. Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus.
Peng W; Li H; Hallstrøm S; Peng N; Liang YX; She Q
RNA Biol; 2013 May; 10(5):738-48. PubMed ID: 23392249
[TBL] [Abstract][Full Text] [Related]
9. The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems.
Foster K; Kalter J; Woodside W; Terns RM; Terns MP
RNA Biol; 2019 Apr; 16(4):449-460. PubMed ID: 29995577
[TBL] [Abstract][Full Text] [Related]
10. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.
Jia N; Mo CY; Wang C; Eng ET; Marraffini LA; Patel DJ
Mol Cell; 2019 Jan; 73(2):264-277.e5. PubMed ID: 30503773
[TBL] [Abstract][Full Text] [Related]
11. Cross-cleavage activity of Cas6b in crRNA processing of two different CRISPR-Cas systems in Methanosarcina mazei Gö1.
Nickel L; Ulbricht A; Alkhnbashi OS; Förstner KU; Cassidy L; Weidenbach K; Backofen R; Schmitz RA
RNA Biol; 2019 Apr; 16(4):492-503. PubMed ID: 30153081
[TBL] [Abstract][Full Text] [Related]
12. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
Takeshita D; Sato M; Inanaga H; Numata T
J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
[TBL] [Abstract][Full Text] [Related]
13. Highly efficient primed spacer acquisition from targets destroyed by the Escherichia coli type I-E CRISPR-Cas interfering complex.
Semenova E; Savitskaya E; Musharova O; Strotskaya A; Vorontsova D; Datsenko KA; Logacheva MD; Severinov K
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7626-31. PubMed ID: 27325762
[TBL] [Abstract][Full Text] [Related]
14. Recent Progress in CRISPR/Cas9 Technology.
Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
[TBL] [Abstract][Full Text] [Related]
15. Specificities and functional coordination between the two Cas6 maturation endonucleases in
Reimann V; Ziemann M; Li H; Zhu T; Behler J; Lu X; Hess WR
RNA Biol; 2020 Oct; 17(10):1442-1453. PubMed ID: 32453626
[TBL] [Abstract][Full Text] [Related]
16. Cas5d processes pre-crRNA and is a member of a larger family of CRISPR RNA endonucleases.
Garside EL; Schellenberg MJ; Gesner EM; Bonanno JB; Sauder JM; Burley SK; Almo SC; Mehta G; MacMillan AM
RNA; 2012 Nov; 18(11):2020-8. PubMed ID: 23006625
[TBL] [Abstract][Full Text] [Related]
17. Functional Identification of the
Liu Q; Wang S; Long J; Chen Z; Yang B; Lin F
Front Microbiol; 2021; 12():686715. PubMed ID: 34475857
[TBL] [Abstract][Full Text] [Related]
18. Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein.
Pawluk A; Shah M; Mejdani M; Calmettes C; Moraes TF; Davidson AR; Maxwell KL
mBio; 2017 Dec; 8(6):. PubMed ID: 29233895
[TBL] [Abstract][Full Text] [Related]
19. Determining the Specificity of Cascade Binding, Interference, and Primed Adaptation
Cooper LA; Stringer AM; Wade JT
mBio; 2018 Apr; 9(2):. PubMed ID: 29666291
[TBL] [Abstract][Full Text] [Related]
20. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems.
Fonfara I; Le Rhun A; Chylinski K; Makarova KS; Lécrivain AL; Bzdrenga J; Koonin EV; Charpentier E
Nucleic Acids Res; 2014 Feb; 42(4):2577-90. PubMed ID: 24270795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
